TELEsurveillance of Patients in PostopErative Bridge surgeryAge CoronairE
TELE-PEACE
1 other identifier
interventional
33
1 country
1
Brief Summary
More than 20,000 patients benefit from coronary bypass surgery in France each year. Median discharge without complication is eight days postoperatively, whereas by day four after surgery, hospitalization is only necessary for medical supervision of the occurrence of complications (scar infection, atrial fibrillation, pericardial effusion), waiting for a downstream bed in cardiac rehabilitation. Some studies have shown the feasibility of a return home from day 4 after CABG in the United States and England under some conditions of selection and monitoring of patients. However, there is currently no validated telemonitoring tool for patients in early postoperative coronary bypass surgery. In this pilot study, during hospitalization for early postoperative coronary bypass surgery, a combination of connected devices for the measurement of physiological parameters and for clinical self-evaluation by the patient will be evaluated. The results of this project will be used as a basis for a future larger study in which an early home discharge can be proposed to patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2020
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 10, 2020
CompletedFirst Posted
Study publicly available on registry
January 22, 2020
CompletedStudy Start
First participant enrolled
March 13, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2022
CompletedMay 15, 2023
May 1, 2023
2.3 years
January 10, 2020
May 12, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Blood pressure measured by connected armband
The Evolution of blood pressure will be measured daily by connected armband, from day 4 postoperatively to discharge from hospital.
day 12 postoperatively or discharge from hospital
Temperature measured by connected thermometer
The Evolution of Temperature will be measured daily by connected thermometer, from day 4 postoperatively to discharge from hospital.
day 12 postoperatively or discharge from hospital
Heartbeat measured by connected electrocardiogram
The heartbeat will be measured daily by connected electrocardiogram, from day 4 postoperatively to discharge from hospital.
day 12 postoperatively or discharge from hospital
scar appearance
The Evolution of scar appearance will be measured daily by photography, from day 4 postoperatively to discharge from hospital.
day 12 postoperatively or discharge from hospital
pain measured
The Evolution of pain will be measured daily by an electronic analog visual pain scale, from day 4 postoperatively to discharge from hospital.
day 12 postoperatively or discharge from hospital
Secondary Outcomes (13)
Connected armband measurements
day 12 postoperatively or discharge from hospital
Connected thermometer measurements.
day 12 postoperatively or discharge from hospital
Connected electrocardiogram
day 12 postoperatively or discharge from hospital
photography of scar
day 12 postoperatively or discharge from hospital
analog visual pain scale
day 12 postoperatively or discharge from hospital
- +8 more secondary outcomes
Study Arms (1)
patient
EXPERIMENTALinterventional group
Interventions
a combination of connected devices for measuring physiological parameters and for clinical self-assessment by the patient, for early postoperative coronary bypass surgeries.
Eligibility Criteria
You may qualify if:
- Patients 18 years of age or older at baseline
- Patient for whom isolated coronary bypass was performed
- From the 4th day after surgery, ECG of the day in sinus rhythm
- From the 4th day after surgery, hemoglobin\> 8g / dl, creatinine clearance\> 30ml / min, during a blood sample of less than 24 hours
- From the 4th day after the operation, no significant abnormalities during a chest X-ray less than 24 hours
- From the 4th day after surgery, FEVG\> 30%, dry pericardium or pericardial effusion ≤ 1cm without compression during transthoracic echocardiography less than 24 hours
You may not qualify if:
- Patients at high risk of complications:
- Insulinorequising diabetics,
- Non-autonomous,
- With a context unfavorable to the implementation of the intervention: patient speaking little or no French, patient without social coverage, patient unable to manage complex actions on connected tools.
- Refusal to sign the consent. Protected persons (tutorship, safeguard of justice)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Assistance Publique - Hôpitaux de Parislead
- GFIcollaborator
Study Sites (1)
Cimadevilla
Paris, France
Study Officials
- PRINCIPAL INVESTIGATOR
Claire Cimadevilla
APHP
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 10, 2020
First Posted
January 22, 2020
Study Start
March 13, 2020
Primary Completion
June 30, 2022
Study Completion
December 31, 2022
Last Updated
May 15, 2023
Record last verified: 2023-05